Three Novel EGFR Mutations (750_758del, I759S, T751_I759delinsS) in One Patient with Metastatic Non-Small Cell Lung Cancer Responding to Osimertinib: A Case Report

Generations of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) can significantly improve the outcome of EGFR-positive NSCLC patients. However, acquired TKIs-resistant mutations are inevitable. Except the common EGFR alterations, more and more rare mutations are revealed by ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huiying, Yu, Tingting, Lin, Yongjuan, Xie, Yu, Feng, Jie, Huang, Mingmin, Guo, Aibin, Liu, Xiangyu, Yin, Zhenyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493011/
https://www.ncbi.nlm.nih.gov/pubmed/32982275
http://dx.doi.org/10.2147/OTT.S259616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493011/
https://www.ncbi.nlm.nih.gov/pubmed/32982275
http://dx.doi.org/10.2147/OTT.S259616

Ejemplares similares